Gabapentin Tablet
Product Images NDC 82804-193

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82804-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clcr (Equation)

This is a formula for calculating creatinine clearance (CLCr) in patients. It involves multiplying the patient's age in years minus 140 by their weight in kilograms, and then multiplying 72 by their serum creatinine level in mg/dL. Adjustment by multiplying the result by 0.85 for female patients is also mentioned in the text.*

FDA Label Image

Figure-1 (Figure1)

This is a graph displaying the weekly mean pain scores observed in the ITT population for Study 1. The graph shows the pain scores over eight weeks with the baseline being zero. There is a comparison between Gabapentin at 3500 iy and a placebo.*

FDA Label Image

Figure-2 (Figure2)

FDA Label Image

Figure-3 (Figure3)

This description provides information about the proportion of responders in patients with >50% reduction in pain score at the endpoint of Controlled Postherpetic Neuralgia (PHN) Studies. Study 1 and Study 2 are compared in terms of patient response rates to treatments such as PBO, GBP 1800, and GBP 2400. The data shows the percentage of responders in each group, with statistical significance indicated by p-values.*

FDA Label Image

Figure-4 (Figure4)

This text gives information about the Responder Rate in Patients Receiving Gabapentin as shown in Figure 4. It addresses the difference from placebo by dose and study in Adjunctive Therapy Studies for patients over 12 years of age with partial seizures. The data is presented in a graph format displaying the daily dose in milligrams and the responder rate in percentage. The doses mentioned are 600, 900, 1200, and 1800 mg. Different studies (a, b, c) are compared in terms of their results.*

FDA Label Image

82804-193-90 (Image 01)

This document contains information about a medication called Gabapentin 600mg, including the packaging details, tablet description, expiration date, and storage instructions. The medication is in the form of white-colored film-coated oval-shaped tablets with specific markings. It is important to dispense the Medication Guide provided separately to each patient. The medication should be stored at 25°C (77°F) and kept out of the reach of children.*

FDA Label Image

Struc (Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.